🔄

Gemini Labs Tirzepatide 10mg

$140.00 $184.00

| /

Gemini Labs Tirzepatide 10mg

For Research Use Only. Not for human consumption.
This product is not approved by the FDA for human use. Intended strictly for laboratory research purposes only

Researched Benefits

  • Research-grade peptide
  • Lyophilized powder format
  • Reliable purity for laboratory testing

Does not include any syringe nor bac water.

Tirzepatide 10mg (comes in a 3ml glass vial ) is a research-grade peptide offered in lyophilized form for advanced laboratory applications. Sourced and handled with precision, this compound meets the standards required for researchers conducting peptide-related studies.

It is described in scientific literature as a dual GIP and GLP‑1 receptor agonist. It is a 39‑amino‑acid polypeptide engineered for enhanced stability and is used in laboratory settings to study metabolic pathways, insulin signaling, and glucose regulation.

As a dual‑agonist analogue, tirzepatide mimics the activity of natural GIP and GLP‑1 hormones, allowing researchers to investigate mechanisms related to metabolic function and weight‑regulation biology.

This compound is provided strictly for laboratory research use. It is not approved for human or veterinary use, and all information is intended for non‑clinical, educational, and research‑focused purposes only.

Clinical Trial Outcomes (High‑Level Summary) Large, multi‑phase clinical trials have demonstrated that tirzepatide groups achieved greater reductions in body weight and improved metabolic outcomes compared to placebo and other comparators. These findings have positioned tirzepatide as one of the most impactful metabolic research compounds studied to date.

Safety Observations in Research The most common side effects reported in research settings are gastrointestinal, including nausea, vomiting, diarrhea, and abdominal discomfort—typically during dose escalation. Research also highlights the importance of monitoring for rare but serious events such as allergic reactions, pancreatitis, thyroid‑related findings, and renal concerns. These observations reinforce the need for controlled environments and qualified oversight.

Additional Research Considerations Studies note potential interactions with oral contraceptives, the importance of gradual titration to reduce GI effects, and the need for careful monitoring in populations with certain pre‑existing conditions. Research protocols also emphasize rotating injection sites to reduce local reactions.

Overall Research Perspective Tirzepatide represents a major advancement in metabolic research due to its dual‑receptor activity and strong performance across metabolic endpoints. While its effects have been extensively studied, it remains essential that tirzepatide be used only within approved research settings and handled by qualified professionals following established guidelines.

Research compounds should be stored in a cool, dry environment away from direct light. For longer-term laboratory storage, freezing at approximately −20°C is commonly referenced in research settings to help maintain compound integrity.

Dosage & Administration — Research Summary

In published research, tirzepatide is typically administered as a once‑weekly subcutaneous injection. Studies commonly begin with a low starting amount to observe tolerance, followed by gradual increases to evaluate dose‑dependent effects on metabolic markers. Escalation schedules in the literature often progress through multiple incremental levels to assess how different doses influence outcomes.

Research consistently notes that tirzepatide’s effects are influenced by both dosage and duration of exposure, and that gradual titration is used in studies to help reduce gastrointestinal side effects during early phases.

Lifestyle factors—such as nutrition and physical activity—are frequently included alongside tirzepatide in clinical research designs, as these variables can influence metabolic outcomes and help researchers understand the compound’s full effect profile.

Tirzepatide information on this page is provided strictly for laboratory research use. It is not approved for human or veterinary use, and any handling should follow appropriate research‑use guidelines.

Important: This product is not approved for human consumption and is strictly intended for research use only.